IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

First FDA warning letter for nonpayment of GDUFA fee issued against German manufacturer

11:20 AM MDT | October 8, 2013 | Deepti Ramesh

US FDA has issued a warning letter to C.P.M. ContractPharma (Feldkirchen-Westerham, Germany), a contract manufacturing firm, for failing to self-identify and pay its annual fee as required under FDA’s Generic Drug User Fee Amendments of 2012 (GDUFA). The facility has been placed on a publicly available arrears list, FDA says. “Failure to correct these violations promptly may result in regulatory action, including seizure or injunction without further notice; and the facility may also be placed on import alert such that any drug the facility...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa